Skip to main content
TipRanks
Go Ultimate75% OFF

Veri Medtech Holdings (VRHI) Ratios

5 Followers

Veri Medtech Holdings Ratios

VRHI's free cash flow for Q3 2026 was $33.06K. For the 2026 fiscal year, VRHI's free cash flow was decreased by $-4.00 and operating cash flow was $33.06K. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio0.05―1118.250.000.68
Quick Ratio0.05―1118.250.000.68
Cash Ratio0.02―1118.250.000.68
Solvency Ratio-0.87―-14.13-0.63-0.11
Operating Cash Flow Ratio0.13―-4848.750.00-0.23
Short-Term Operating Cash Flow Coverage0.61―0.000.000.00
Net Current Asset Value$ -2.42M―$ 22.59K$ -28.96K$ -86.80K
Leverage Ratios
Debt-to-Assets Ratio2.83―0.000.000.00
Debt-to-Equity Ratio-0.22―0.000.000.00
Debt-to-Capital Ratio-0.28―0.000.000.00
Long-Term Debt-to-Capital Ratio0.00―0.000.000.00
Financial Leverage Ratio-0.08―1.031.284.49
Debt Service Coverage Ratio-3.65―0.000.000.00
Interest Coverage Ratio-33.28―0.000.000.00
Debt to Market Cap0.02―0.000.000.00
Interest Debt Per Share0.07―0.000.000.00
Net Debt to EBITDA-0.22―0.450.805.97
Profitability Margins
Gross Profit Margin75.28%―85.49%83.05%76.53%
EBIT Margin-20.89%―-79.26%-156.70%-454.71%
EBITDA Margin-19.84%―-76.75%-154.75%-62.99%
Operating Profit Margin-20.89%―-79.26%-156.70%-454.71%
Pretax Profit Margin-21.53%―-79.26%-156.70%-65.96%
Net Profit Margin-21.53%―-79.26%-156.70%-65.96%
Continuous Operations Profit Margin-21.53%―-79.26%-156.70%-454.71%
Net Income Per EBT100.00%―100.00%99.99%100.00%
EBT Per EBIT103.05%―100.00%100.00%14.51%
Return on Assets (ROA)-1263.34%―-37.20%-13.81%-9.29%
Return on Equity (ROE)98.92%―-38.17%-17.64%-41.75%
Return on Capital Employed (ROCE)95.99%―-37.20%-13.81%-287.82%
Return on Invested Capital (ROIC)123.26%―-37.20%-13.81%-287.82%
Return on Tangible Assets-1263.34%―-37.20%-13.81%-9.29%
Earnings Yield-9.34%―-0.43%-0.15%-0.09%
Efficiency Ratios
Receivables Turnover1643.67―0.000.000.00
Payables Turnover1.87―472.290.000.04
Inventory Turnover0.00―0.000.000.00
Fixed Asset Turnover181.58―10.380.430.82
Asset Turnover58.68―0.470.090.14
Working Capital Turnover Ratio-4.40―2.61-0.941.75
Cash Conversion Cycle-195.35―-0.770.00-8584.54
Days of Sales Outstanding0.22―0.000.000.00
Days of Inventory Outstanding0.00―0.000.000.00
Days of Payables Outstanding195.57―0.770.008584.54
Operating Cycle0.22―0.000.000.00
Cash Flow Ratios
Operating Cash Flow Per Share0.04―-0.00-0.00-0.00
Free Cash Flow Per Share0.04―-0.00-0.00-0.00
Dividend Paid and CapEx Coverage Ratio102.77―0.000.00-62.15
Capital Expenditure Coverage Ratio102.77―0.000.00-62.15
Operating Cash Flow Coverage Ratio0.61―0.000.000.00
Operating Cash Flow to Sales Ratio0.03―-1.49-1.65-1.26
Free Cash Flow Yield1.26%―-0.80%-0.16%-0.17%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-10.43―-236.36-685.71-168.64
Price-to-Sales (P/S) Ratio2.30―185.041060.36761.60
Price-to-Book (P/B) Ratio-10.59―89.12119.34482.07
Price-to-Free Cash Flow (P/FCF) Ratio79.06―-124.22-642.96-595.72
Price-to-Operating Cash Flow Ratio78.29―-124.22-642.96-605.31
Price-to-Earnings Growth (PEG) Ratio-0.04―-4.148.15-2.02
Enterprise Value Multiple-11.84―-240.64-684.39-1203.18
Enterprise Value25.48M―14.43M26.66M37.36M
EV to EBITDA-11.84―-240.64-684.39-1203.18
EV to Sales2.35―184.691059.13757.84
EV to Free Cash Flow80.57―-123.99-642.22-592.78
EV to Operating Cash Flow79.79―-123.99-642.22-602.32
Tangible Book Value Per Share-0.30―0.000.000.00
Shareholders’ Equity Per Share-0.30―0.000.000.00
Tax and Other Ratios
Effective Tax Rate0.00―0.000.000.00
Revenue Per Share1.36―0.000.000.00
Net Income Per Share-0.29―-0.00-0.00-0.00
Tax Burden1.00―1.001.001.00
Interest Burden1.03―1.001.000.15
Research & Development to Revenue0.00―0.000.000.04
SG&A to Revenue0.96―1.652.400.17
Stock-Based Compensation to Revenue0.00―0.000.000.00
Income Quality-0.14―1.881.051.91

Currency in USD